SlideShare a Scribd company logo
1 of 10
Download to read offline
Coursework Template for E-submission
BMS
Student name Adina Georgiana Dorobantu
Student number 30019475
Module name Biomedical Investigations
Title of coursework Luminex bead-based essay
Instructions:
1) Complete your name and student number above.
2) Save your file as: YOUR surname_Initial_essay_2021-22.docx
eg Cross_A_essay_2021-22.docx
3) Insert your work on page 2 so that the feedback form and marking criteria are on the last pages
4) Submit your work to the Blackboard submission tool on the Blackboard site,
Submit your work as a Word file (not pdf).
Insert learning contract
details here if applicable.
Technique based essay:
Insert your work here
Luminex bead-based assay
Scientific Theory
Since it was first discovered and introduced in 1995, the Luminex bead-based assay has revolutionized
the approach of scientists in both research and clinical settings, due to the great advantages it brought to
already existing techniques, the most common of which being the ELISA (Bourdon, 2016). Therefore, the
objective of this technique guide is to create a comparative analysis between these two similar assays, while
emphasizing the improvements brought on by Luminex through xMAP Luminex technology (see Table 1).
The multiplex Luminex technology has been developed starting from and improving the concept of
single-plex `sandwich` ELISA (can only detect one analyte at a time), where the antigen is caught between two
different antibodies, one recognizing the antigen and one used for its detection of binding and therefore, its
specific and sensitive quantification (“What is a Luminex Assay?,” 2017). Following the same concept, the
principle behind xMAP Luminex technology is based on the use of color-coded 5.6 µm beads, which have
been impregnated with different ratios of infrared and red dyes (fluorophores), allowing subsequent detection
of unique bead regions specific for certain analytes, that can be identified on the resulting spectra (Principle of
the Luminex Multiplex Bead Immunoassay Method, n.d.).
Additionally, each bead is further coated with specific capture antibodies (Figure 1) (“What is a
Luminex Assay?,” 2017). The multiplex feature of the Luminex assay comes with the advantage of being able
to mix multiple specific beads depending on the required sample for analysis, in order to test for multiple
analytes simultaneously, in the same amount of resources, such as sample volume, incubation time, reagent
amounts, cost (“What is a Luminex Assay?,” 2017).
The sample is added and left to incubate with the bead mixture, ensuring maximal binding and
antibody saturation with analytes of interest, followed by a series of washing steps that ensure elimination of
any unbound materials (Principle of the Luminex Multiplex Bead Immunoassay Method, n.d.). Then, a second
biotinylated antibody linked to a streptavidin-phycoerythrin (PE) fluorescent reporter, also known as the
detection antibody, is added to the mixture and incubated (Figure 1) (Principle of the Luminex Multiplex Bead
Immunoassay Method, n.d.).
The next step of the Luminex assay is the two-way flow cytometry detection system: firstly, a red laser
is used for the excitation of the bead region, together with the bound analyte, respectively; secondly, a second
green laser is used to determine the PE fluorescent reporter signal, which can also be correlated as having a
directly proportional relationship to the amount of bound analyte (Figure 1) (“What is a Luminex Assay?,”
2017). In other words, the more analyte detected by the capture antibodies on certain bead-regions, the
stronger the fluorescence signal, and therefore, the higher the value read by the xMAP Luminex analyser
(“What is a Luminex Assay?,” 2017). Alternatively, measurement of this assay can also be done using the
LED system (“What is a Luminex Assay?,” 2017).
As an immunoassay, xMAP Luminex technology is currently being used in order to measure the
`amount` of various analytes, such as cytokines, chemokines and other biomarkers, mostly present during an
immunological response, which are essential in the better understanding of diseases and their manifestations
(Günther, Becker, Göpfert, Joos, & Schneiderhan-Marra, 2020).
For the purpose of the following and future analysis, it should be mentioned that variability is to be
expected between different Luminex assay and ELISA kit producers.
Figure 1. The mechanism behind the Luminex bead-based assay. This diagram outlines the successive steps
of the Luminex assay. It depicts the Luminex bead (shown in red as a suggestion to the dyes used) with its
capture antibody linked to it, which recognized the analyte of interest. Furthermore, the detection antibody
with the linked PE reporter is also observed, as well as the overall bound complex, which is then measured by
the use of red and green lasers (as seen on the right side of the diagram) Diagram retrieved from (Bourdon,
2016).
Luminex bead-based assay ELISA
Analyte capacity Multiplex Single-plex
Ease of use  More accessible and easy
to use
 Easily adjustable
(duPont, Wang, Wadhwa,
Culhane, & Nelson, 2005)
 Labour intenstive
(duPont, Wang, Wadhwa, Culhane,
& Nelson, 2005)
Sample size  25 - 50 µL/ multiple
samples
 This directly influences
and significantly lowers
the cost of the assay
(Mountjoy, 2020)
 50 - 100 µL/ sample
(recommended)
(Mountjoy, 2020)
Coating antibody
(capture antibody)
amount needed
(/well)
 7.5 ng (over 50x the
amount needed for
ELISA/well)
 This is also reflected in a
lower overall assay cost
(Baker, Murphy, Lopez, &
Garcia, 2012)
 400 ng
(Baker, Murphy, Lopez, & Garcia,
2012)
Accuracy  Similar or equivalent for
most analytes
 However, this can be
overcome by higher
numbers of measured
analytes in a shorter
period of time
(Shapiro, Wang, Mendu & Firpo,
2020)
 Similar or equivalent
 Slightly more accurate for a
small number of analytes
(Shapiro, Wang, Mendu & Firpo,
2020)
Sensitivity  <4 pg/mL
(Baker, Murphy, Lopez, &
Garcia, 2012)
 >31 pg/mL
(Baker, Murphy, Lopez, & Garcia,
2012)
Cross reactivity Low chance High chance
Specificity and
affinity
 Optimal at the
appropriate parameters
for the analyzed sample
(duPont, Wang, Wadhwa,
Culhane, & Nelson, 2005)
 Cross-reactivity can
interfere
(“Overview of ELISA | Thermo
Fisher Scientific - UK,” 2022)
Detection range  <4 pg/mL to >8000
pg/mL
 Allows a broader range to
be detected by the plate
reader, between OD 3 or
4
(Baker, Murphy, Lopez, &
Garcia, 2012)
 16 pg/mL to 1000 pg/mL
 Could restrict the plate
reading ability due to the
low upper limit
(Baker, Murphy, Lopez, & Garcia,
2012)
Time  ≤ 3h
 Translates to higher
throughout
(Baker, Murphy, Lopez, &
Garcia, 2012)
 ≥ 24h
 Translates to lower
throughput
(Baker, Murphy, Lopez, & Garcia,
2012)
Cost Around 30% less compared to
ELISA, due to smaller amounts
of material needed for analysis of
multiple analytes (£)
(duPont, Wang, Wadhwa,
Culhane, & Nelson, 2005)
Higher cost, due to higher amount
of materials needed for analysis of
multiple analytes (£££)
(duPont, Wang, Wadhwa, Culhane,
& Nelson, 2005)
Type pf plate and
binding surface area
 Carried out in 96-well or
384-well plates
 Due to the beads being
held in suspension, less
capture antibody is
required, as well as a
lower sample amount
(Baker, Murphy, Lopez, &
Garcia, 2012)
 Usually carried out in a 96-
well or 384-well
polystyrene plates
 The flat-surface used
requires increased capture
antibody for coating the
wells and a corresponding
larger sample amount
(Baker, Murphy, Lopez, & Garcia,
2012)
Table 1. Comparative analysis between the Luminex bead-based assay and ELISA
Applications
A recent study “Evaluating SARS-CoV-2 spike and nucleoplasmid proteins as targets for antibody
detection in severe and mild COVID-19 cases using a Luminex bead-based assay (Mariën et al., 2021) can be
considered a very good example that proves the high and continuously developing applicability of this
technique. The paper describes the context of choosing the Luminex bead assay, in the detriment of the already
existing ELISA test that however, due to the high demand, is slowly becoming increasingly harder to sustain,
financially, but also disadvantageous and inaccurate over a long period of time, because of suboptimal
specificity and single-plex mechanism (Mariën et al., 2021).
Moreover, the high accuracy, specificity and sensitivity of multiplex Luminex technology measuring
the spike (S) and nucleoplasmid (NP) analytes was carried out on a diversity of recent and old infection cases,
as well as sever, mild and asymptomatic cases (Mariën et al., 2021).
The combination of two SARS-CoV-2 analytes as part of the multiplex Luminex assay generated
considerably higher specificity, that could be used in future test developments, for example, to be distributed in
underdeveloped countries, such as the sub-Saharan Africa, where occurrence of false-positive ELISA tests is
elevated due to the influence of other infectious diseases (Mariën et al., 2021).
The current relevance of this study demonstrates the reliability of the xMAP Luminex technology in
easily adapting to development of novel diagnostic tests, even for a rapidly spreading infectious disease, which
could only encourage an increasing interest in future diversification of this technique.
Reference List
Baker, H. N., Murphy, R., Lopez, E., & Garcia, C. (2012). Conversion of a Capture ELISA to a Luminex xMAP Assay using a
Multiplex Antibody Screening Method. Journal of Visualized Experiments, (65). https://doi.org/10.3791/4084
Bourdon D. (2016, May 19). LuminexTM
 bead-based immunoassays drive immunoassays towards higher-content biomarker
discovery. Retrieved February 3, 2022, from Behind the Bench website:
https://www.thermofisher.com/blog/behindthebench/luminex-bead-based-immunoassays-drive-immunoassays-
towards-higher-content-biomarker-discovery/
duPont, N. C., Wang, K., Wadhwa, P. D., Culhane, J. F., & Nelson, E. L. (2005). Validation and comparison of luminex multiplex
cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture
supernatants. Journal of Reproductive Immunology, 66(2), 175–191. https://doi.org/10.1016/j.jri.2005.03.005
Günther, A., Becker, M., Göpfert, J., Joos, T., & Schneiderhan-Marra, N. (2020). Comparison of Bead-Based Fluorescence
Versus Planar Electrochemiluminescence Multiplex Immunoassays for Measuring Cytokines in Human
Plasma. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.572634
Mariën, J., Ceulemans, A., Michiels, J., Heyndrickx, L., Kerkhof, K., Foque, N., … Ariën, K. K. (2021). Evaluating SARS-CoV-2
spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a
Luminex bead-based assay. Journal of Virological Methods, 288, 114025.
https://doi.org/10.1016/j.jviromet.2020.114025
‌
Mountjoy K.G. (2020) ELISA versus LUMINEX assay for measuring mouse metabolic hormones and cytokines: sharing the
lessons I have learned. Retrieved February 3, 2022, from Journal of Immunoassay and Immunochemistry website:
https://www.tandfonline.com/doi/full/10.1080/15321819.2020.1838924
Overview of ELISA | Thermo Fisher Scientific - UK. (2022). Retrieved February 3, 2022, from Thermofisher.com website:
https://www.thermofisher.com/uk/en/home/life-science/protein-biology/protein-biology-learning-center/
protein-biology-resource-library/pierce-protein-methods/overview-elisa.html#:~:text=The%20enzyme%20linked
%20immunosorbent%20assay,microplate%20wells%20using%20specific%20antibodies
PRINCIPLE OF THE LUMINEX MULTIPLEX BEAD IMMUNOASSAY METHOD. (n.d.). Retrieved from https://cdn
links.lww.com/permalink/sla/b/sla_2017_07_03_allen_annsurg-d-17-00426_sdc1.pdf (pp. 3, 7, 12-13)
Shapiro, M S; Wang, X; Mendu, D R; Firpo (2020) Multiplex Assays of Luminex for Identification of COVID-19 Antibodies in
Patient Serum: Performance Evaluation and Comparison to ELISA, A.American Journal of Clinical Pathology, suppl.
1; Chicago Vol. 154, (Oct 2020): S92. DOI:10.1093/ajcp/aqaa161.201, Retrieved February 3, 2022, from
Proquest.com website: https://www.proquest.com/openview/d6c8b8d6d42fd46a252b18220b5f4213/1?pq-
origsite=gscholar&cbl=586299
What is a Luminex Assay? (2017). Retrieved February 3, 2022, from www.rndsystems.com website:
https://www.rndsystems.com/what-luminex-assay
Faculty of Health and Wellbeing - Department of Biosciences
ASSESSED WORK FEEDBACK FORM
Student Name:
Module Title: Biomedical Investigations
Title of coursework Technique based structured essay
Marker:
Grade
Strengths:
Weaknesses and suggestions for improvement
Student comments for Feed-forward (how will you use this feedback to improve your future work?):
SIGNATURE DATE:
*A provisional mark may be raised or lowered by the External Examiner or the Exam Board
Indicator First
(Exceptional)
First (Excellent) Upper second
(Very good)
Lower Second
(Good)
Third
(Sufficient)
Fail
(Insufficient)
Low/Zero Fail
Overall
Knowledge and
Understanding
(weighting
20%)
Shows advanced
understanding of key
subject area. Excellent
level of originality with
a wide range of
relevant literature
accessed.
Excellent grasp of
relevant literature and
sound understanding
of subject area.
Evidence of originality.
Very good
understanding of the
area. Appreciation of
wider implications,
and a serious attempt
to engage with
breadth of relevant
literature
Good understanding
of subject area.
Evidence of a
reasonably sound
engagement with
relevant literature.
May contain minor
errors.
Sufficient or
inconsistent grasp of
material. Evidence
of some
understanding of
subject area.
Limited research
and major errors.
Insufficient. Partial
answer with major
omissions. Poor
understanding.
Scarce amount of
research.
Little or no attempt to
address the question.
Brief or wholly irrelevant
answer.
Scientific
theory with
diagram
(weighting
30%)
Outstanding scientific
theory. Clearly and
concisely written.
Flows well. Excellent
diagram with clear
explanatory legend
Excellent theory, Clear
and coherent.
Excellent diagram with
appropriate legend
Very good theory.
Clear and coherent.
Clear diagram with
appropriate legend
Good explanation of
theory. Diagram
included. Figure
legend included
Sufficient
explanation. Lacks
coherence and
clarity in many
areas. Poor choice
of diagram. Legend
does not explain
figure well.
Insufficient theory.
Explanation lacks
focus. Incoherent,
and lacks clarity
throughout. Poor
diagram, legend
missing or irrelevant.
Very poor with no
structure or focus.
No attempt at figure or
figure legend
Table of
comparison to
another
technique
(weighting
20%)
Outstanding critical
analysis.
Excellent use of
literature to illustrate
comparisons
Excellent standard of
intelligent, critical
thought and argument.
Good use of literature
to illustrate
comparisons
Very good evidence
of independent
thinking and critical
analysis. Relevant
material.
Good evidence of
critical analysis
Limited use of
literature to illustrate
comparisons
Sufficient/ weak
critical analysis. An
attempt to answer
the question but
may lack relevance
and very little use of
literature
Unfocused.
Insufficient
engagement with
literature
No understanding of the
issues and little attempt to
address them
Application of
use
(weighting
20%)
Outstanding account of
application discussed.
Accurately
communicated. Benefits
fully explained
Excellent
understanding of the
applications. Highly
relevant applications
incl. Clearly and
effectively written.
Benefits well explained
Very good
understanding of the
applications. Relevant
choices with some
appropriate critique
Benefits explained
Good understanding
of the applications
discussed. Relevant
choices made,
benefits included
Sufficient/ limited
explanation of
applications of use,
unfocused and
lacking depth.
Insufficient attempt
to explain
applications,
sources of
information poor or
inappropriate
Little or no attempt to
discuss applications of
use
Referencing
(weighting
10%)
Excellent and
appropriate use of
referencing
throughout. No errors.
Outstanding reference
choice throughout
Refs correct and
thorough. Bibliography
complete- properly laid
out. Very minor errors.
Excellent ref choice
throughout
References accurate.
Bibliography
complete and
properly laid out.
Minor errors. Very
good ref. choice
Generally correct
but needs some
attention.
Some good
reference choices
Some incorrect
referencing and
incomplete or not
properly laid out
bibliography.
Insufficient or no
proper referencing.
Bibliography
inadequate. Poor
choice of references
No referencing
Class CG% General Characteristics Level 5
9
FIRST
(Excellent}
96 Exceptional breadth and depth of knowledge and understanding of the area of study; evidence of extensive and appropriate selection and critical
evaluation/synthesis/analysis and of reading/research beyond the prescribed range, in both breadth and depth, to advance work/direct
arguments; exceptional demonstration of relevant skills; excellent communication; performance deemed to be beyond expectation.
89
81 Outstanding/excellent knowledge and understanding of the area of study as the student is typically able to go beyond what has been taught
(particularly for a mid/high 1st
); evidence of extensive and appropriate selection and critical evaluation/synthesis/ analysis of reading/research
beyond the prescribed range, to advance work/direct arguments; excellent demonstration of relevant skills; excellent communication;
performance deemed beyond expectation of the level.
74
UPPER SECOND
(Very good)
68 Very good knowledge and understanding of the area of study as the student is typically able to relate facts/concepts together with some
ability to apply to known/taught contexts; evidence of appropriate selection and evaluation of reading/research, some beyond the prescribed
range, may rely on set sources to advance work/direct arguments; demonstrates autonomy in approach to learning; very good
demonstration of relevant skills; strong communication skills.
65
62
LOWER SECOND
(Good)
58 Good knowledge and understanding of the area of study balanced towards the descriptive rather than analytical; evidence of appropriate selection
and evaluation of reading/research but generally reliant on set sources to advance work/direct arguments; good demonstration of relevant skills,
though may be limited in range; communication shows clarity but structure may not always be coherent.
55
52
THIRD
(Sufficient)
48 Knowledge and understanding is sufficient to deal with terminology, basic facts and concepts but fails to make meaningful synthesis; some
ability to select and evaluate reading/research however work may be more generally descriptive; strong reliance on available support set sources
to advance work; arguments may be weak or poorly constructed; adequate demonstration of relevant skills over a limited range;
communication/presentation is generally competent but with some weaknesses.
45
42
FAIL
(Insufficient)
35
Insufficient knowledge and understanding of the area of study; some ability to select and evaluate reading/research however work is more
generally descriptive; fails to address some aspects of the brief; a limited use of sources to advance work; arguments may be weak/poor or
weakly/poorly constructed; demonstration of relevant skills over a reduced range; communication shows limited clarity, poor presentation,
structure may not be coherent.
25
15
Highly insufficient knowledge or understanding of the area of study; understanding is typically at the word level with facts being reproduced in a
disjointed or decontextualised manner; fails to address the outcomes addressed by the brief; typically ignores important sources in development of
work and data/evidence inappropriately used; weak technical and practical competence hampers ability to demonstrate/communicate achievement of
outcomes.
5
Zero 0 Work of no merit OR absent, work not submitted, penalty in some misconduct cases.
10

More Related Content

What's hot

Immunologic laboratory-tests
Immunologic laboratory-testsImmunologic laboratory-tests
Immunologic laboratory-testsdream10f
 
Lateral Flow Assay LSA
Lateral Flow Assay LSALateral Flow Assay LSA
Lateral Flow Assay LSAMNNIT
 
Immunoassay basic concepts for clinical pathologist
Immunoassay basic concepts for clinical pathologistImmunoassay basic concepts for clinical pathologist
Immunoassay basic concepts for clinical pathologistDr. Rajesh Bendre
 
Clinical laboratory total quality management (TQM) system
Clinical laboratory total quality management (TQM) systemClinical laboratory total quality management (TQM) system
Clinical laboratory total quality management (TQM) systemTapeshwar Yadav
 
GNB resistance and choice of antibiotics.pptx
GNB resistance and choice of antibiotics.pptxGNB resistance and choice of antibiotics.pptx
GNB resistance and choice of antibiotics.pptxrahul amte
 
Lpa and Genexpert/CBNAAT/Xpert MTB/Rif
Lpa and Genexpert/CBNAAT/Xpert MTB/RifLpa and Genexpert/CBNAAT/Xpert MTB/Rif
Lpa and Genexpert/CBNAAT/Xpert MTB/RifKalai Arasan
 
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain ShamsQuality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain ShamsAdel Elazab Elged
 
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS - Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS - SOMESHWARAN R
 
Counter immunoelectrophoresis
Counter immunoelectrophoresisCounter immunoelectrophoresis
Counter immunoelectrophoresisAhmedRiyadh17
 
Enzyme linked immunosorbent assay (elisa) and its clinical significance
Enzyme linked immunosorbent assay (elisa) and its clinical significanceEnzyme linked immunosorbent assay (elisa) and its clinical significance
Enzyme linked immunosorbent assay (elisa) and its clinical significancerohini sane
 
Serological Diagnosis of Infectious Diseases
Serological Diagnosis of Infectious DiseasesSerological Diagnosis of Infectious Diseases
Serological Diagnosis of Infectious DiseasesMostafa Mahmoud
 

What's hot (20)

Immunologic laboratory-tests
Immunologic laboratory-testsImmunologic laboratory-tests
Immunologic laboratory-tests
 
Elisa
ElisaElisa
Elisa
 
Lateral Flow Assay LSA
Lateral Flow Assay LSALateral Flow Assay LSA
Lateral Flow Assay LSA
 
Immunoassay basic concepts for clinical pathologist
Immunoassay basic concepts for clinical pathologistImmunoassay basic concepts for clinical pathologist
Immunoassay basic concepts for clinical pathologist
 
Electrochemiluminescent (ecl)
Electrochemiluminescent (ecl)Electrochemiluminescent (ecl)
Electrochemiluminescent (ecl)
 
Clinical laboratory total quality management (TQM) system
Clinical laboratory total quality management (TQM) systemClinical laboratory total quality management (TQM) system
Clinical laboratory total quality management (TQM) system
 
Carbapenamases. facts detection and concerns by Dr.T.V.Rao MD
Carbapenamases. facts detection and concerns by Dr.T.V.Rao MDCarbapenamases. facts detection and concerns by Dr.T.V.Rao MD
Carbapenamases. facts detection and concerns by Dr.T.V.Rao MD
 
GNB resistance and choice of antibiotics.pptx
GNB resistance and choice of antibiotics.pptxGNB resistance and choice of antibiotics.pptx
GNB resistance and choice of antibiotics.pptx
 
Lpa and Genexpert/CBNAAT/Xpert MTB/Rif
Lpa and Genexpert/CBNAAT/Xpert MTB/RifLpa and Genexpert/CBNAAT/Xpert MTB/Rif
Lpa and Genexpert/CBNAAT/Xpert MTB/Rif
 
Quality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain ShamsQuality control lecture CPath master 2014 Ain Shams
Quality control lecture CPath master 2014 Ain Shams
 
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS - Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
 
Elisa
ElisaElisa
Elisa
 
Esbl
EsblEsbl
Esbl
 
Counter immunoelectrophoresis
Counter immunoelectrophoresisCounter immunoelectrophoresis
Counter immunoelectrophoresis
 
Enzyme linked immunosorbent assay (elisa) and its clinical significance
Enzyme linked immunosorbent assay (elisa) and its clinical significanceEnzyme linked immunosorbent assay (elisa) and its clinical significance
Enzyme linked immunosorbent assay (elisa) and its clinical significance
 
Tuberculosis Diagnosis
Tuberculosis Diagnosis Tuberculosis Diagnosis
Tuberculosis Diagnosis
 
Elis as 1
Elis as 1Elis as 1
Elis as 1
 
Immunochemical techniques
Immunochemical techniquesImmunochemical techniques
Immunochemical techniques
 
Serological Diagnosis of Infectious Diseases
Serological Diagnosis of Infectious DiseasesSerological Diagnosis of Infectious Diseases
Serological Diagnosis of Infectious Diseases
 
Elisa pptx
Elisa  pptxElisa  pptx
Elisa pptx
 

Similar to Dorobantu_A_Luminex-bead-based assay - Feedback.pdf

Mass Spectrometry reviews 2008 v27 p20
Mass Spectrometry reviews 2008 v27 p20 Mass Spectrometry reviews 2008 v27 p20
Mass Spectrometry reviews 2008 v27 p20 Peter Tidswell
 
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...KBI Biopharma
 
AlsadiqPropertiesAndConcentratio.pdf
AlsadiqPropertiesAndConcentratio.pdfAlsadiqPropertiesAndConcentratio.pdf
AlsadiqPropertiesAndConcentratio.pdfHamza Deeb
 
Combination of informative biomarkers in small pilot studies and estimation ...
Combination of informative  biomarkers in small pilot studies and estimation ...Combination of informative  biomarkers in small pilot studies and estimation ...
Combination of informative biomarkers in small pilot studies and estimation ...LEGATO project
 
Combination of informative biomarkers in small pilot studies and estimation o...
Combination of informative biomarkers in small pilot studies and estimation o...Combination of informative biomarkers in small pilot studies and estimation o...
Combination of informative biomarkers in small pilot studies and estimation o...LEGATO project
 
Predictive microbiology in foods
Predictive microbiology in foodsPredictive microbiology in foods
Predictive microbiology in foodsSpringer
 
Nanobiosensor for diclofop detection based on chemically modified afm probes ...
Nanobiosensor for diclofop detection based on chemically modified afm probes ...Nanobiosensor for diclofop detection based on chemically modified afm probes ...
Nanobiosensor for diclofop detection based on chemically modified afm probes ...Grupo de Pesquisa em Nanoneurobiofisica
 
Nanoparticles as a novel and promising antiviral platform in veterinary medicine
Nanoparticles as a novel and promising antiviral platform in veterinary medicineNanoparticles as a novel and promising antiviral platform in veterinary medicine
Nanoparticles as a novel and promising antiviral platform in veterinary medicineAhmed Hasham
 
Saliency Based Hookworm and Infection Detection for Wireless Capsule Endoscop...
Saliency Based Hookworm and Infection Detection for Wireless Capsule Endoscop...Saliency Based Hookworm and Infection Detection for Wireless Capsule Endoscop...
Saliency Based Hookworm and Infection Detection for Wireless Capsule Endoscop...IRJET Journal
 
Probit analysis in toxicological studies
Probit analysis in toxicological studies Probit analysis in toxicological studies
Probit analysis in toxicological studies kunthavai Nachiyar
 
Chemistry Of Reverse Micelle Based Coatings
Chemistry Of Reverse Micelle Based CoatingsChemistry Of Reverse Micelle Based Coatings
Chemistry Of Reverse Micelle Based CoatingsBeth Salazar
 
MINIMALLY INVASIVE SURGERY IN TOTAL HIP ARTHROPLASTY: A COSTEFFECTIVENESS ANA...
MINIMALLY INVASIVE SURGERY IN TOTAL HIP ARTHROPLASTY: A COSTEFFECTIVENESS ANA...MINIMALLY INVASIVE SURGERY IN TOTAL HIP ARTHROPLASTY: A COSTEFFECTIVENESS ANA...
MINIMALLY INVASIVE SURGERY IN TOTAL HIP ARTHROPLASTY: A COSTEFFECTIVENESS ANA...ELISA HERNANDEZ TORRES
 
A Comparison Of Near Infrared Method Development Approaches Using A Drug Prod...
A Comparison Of Near Infrared Method Development Approaches Using A Drug Prod...A Comparison Of Near Infrared Method Development Approaches Using A Drug Prod...
A Comparison Of Near Infrared Method Development Approaches Using A Drug Prod...Simar Neasy
 

Similar to Dorobantu_A_Luminex-bead-based assay - Feedback.pdf (20)

Mass Spectrometry reviews 2008 v27 p20
Mass Spectrometry reviews 2008 v27 p20 Mass Spectrometry reviews 2008 v27 p20
Mass Spectrometry reviews 2008 v27 p20
 
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
 
AlsadiqPropertiesAndConcentratio.pdf
AlsadiqPropertiesAndConcentratio.pdfAlsadiqPropertiesAndConcentratio.pdf
AlsadiqPropertiesAndConcentratio.pdf
 
SURE poster
SURE posterSURE poster
SURE poster
 
Combination of informative biomarkers in small pilot studies and estimation ...
Combination of informative  biomarkers in small pilot studies and estimation ...Combination of informative  biomarkers in small pilot studies and estimation ...
Combination of informative biomarkers in small pilot studies and estimation ...
 
Combination of informative biomarkers in small pilot studies and estimation o...
Combination of informative biomarkers in small pilot studies and estimation o...Combination of informative biomarkers in small pilot studies and estimation o...
Combination of informative biomarkers in small pilot studies and estimation o...
 
Predictive microbiology in foods
Predictive microbiology in foodsPredictive microbiology in foods
Predictive microbiology in foods
 
biomedicines-03-00203
biomedicines-03-00203biomedicines-03-00203
biomedicines-03-00203
 
Nanobiosensor for diclofop detection based on chemically modified afm probes ...
Nanobiosensor for diclofop detection based on chemically modified afm probes ...Nanobiosensor for diclofop detection based on chemically modified afm probes ...
Nanobiosensor for diclofop detection based on chemically modified afm probes ...
 
Nanoparticles as a novel and promising antiviral platform in veterinary medicine
Nanoparticles as a novel and promising antiviral platform in veterinary medicineNanoparticles as a novel and promising antiviral platform in veterinary medicine
Nanoparticles as a novel and promising antiviral platform in veterinary medicine
 
Saliency Based Hookworm and Infection Detection for Wireless Capsule Endoscop...
Saliency Based Hookworm and Infection Detection for Wireless Capsule Endoscop...Saliency Based Hookworm and Infection Detection for Wireless Capsule Endoscop...
Saliency Based Hookworm and Infection Detection for Wireless Capsule Endoscop...
 
Cellulose nanofiber
Cellulose nanofiberCellulose nanofiber
Cellulose nanofiber
 
Probit analysis in toxicological studies
Probit analysis in toxicological studies Probit analysis in toxicological studies
Probit analysis in toxicological studies
 
pnl_05_en_006_web
pnl_05_en_006_webpnl_05_en_006_web
pnl_05_en_006_web
 
Chemistry Of Reverse Micelle Based Coatings
Chemistry Of Reverse Micelle Based CoatingsChemistry Of Reverse Micelle Based Coatings
Chemistry Of Reverse Micelle Based Coatings
 
poc4life
poc4lifepoc4life
poc4life
 
Thierry_2013_JMM
Thierry_2013_JMMThierry_2013_JMM
Thierry_2013_JMM
 
DSRG report 2001
DSRG report 2001DSRG report 2001
DSRG report 2001
 
MINIMALLY INVASIVE SURGERY IN TOTAL HIP ARTHROPLASTY: A COSTEFFECTIVENESS ANA...
MINIMALLY INVASIVE SURGERY IN TOTAL HIP ARTHROPLASTY: A COSTEFFECTIVENESS ANA...MINIMALLY INVASIVE SURGERY IN TOTAL HIP ARTHROPLASTY: A COSTEFFECTIVENESS ANA...
MINIMALLY INVASIVE SURGERY IN TOTAL HIP ARTHROPLASTY: A COSTEFFECTIVENESS ANA...
 
A Comparison Of Near Infrared Method Development Approaches Using A Drug Prod...
A Comparison Of Near Infrared Method Development Approaches Using A Drug Prod...A Comparison Of Near Infrared Method Development Approaches Using A Drug Prod...
A Comparison Of Near Infrared Method Development Approaches Using A Drug Prod...
 

More from AdinaGeorgiana7

Oral_Presentation_Submission Level 5.pptx
Oral_Presentation_Submission Level 5.pptxOral_Presentation_Submission Level 5.pptx
Oral_Presentation_Submission Level 5.pptxAdinaGeorgiana7
 
Feedback on the Literature Review PSP3 CW
Feedback on the Literature Review PSP3  CWFeedback on the Literature Review PSP3  CW
Feedback on the Literature Review PSP3 CWAdinaGeorgiana7
 
Adina Georgiana Dorobantu Literature review.pdf
Adina Georgiana Dorobantu Literature review.pdfAdina Georgiana Dorobantu Literature review.pdf
Adina Georgiana Dorobantu Literature review.pdfAdinaGeorgiana7
 
3rd (Final) Performance Review Form - AGD Sept2023.pdf
3rd (Final) Performance Review Form - AGD Sept2023.pdf3rd (Final) Performance Review Form - AGD Sept2023.pdf
3rd (Final) Performance Review Form - AGD Sept2023.pdfAdinaGeorgiana7
 
2nd Performance Review Form - ADjuly 2023 .pdf
2nd Performance Review Form - ADjuly 2023 .pdf2nd Performance Review Form - ADjuly 2023 .pdf
2nd Performance Review Form - ADjuly 2023 .pdfAdinaGeorgiana7
 
Performance Review Form 1 (Dec 2022) Adina Georgiana Dorobantu.pdf
Performance Review Form 1 (Dec 2022) Adina Georgiana Dorobantu.pdfPerformance Review Form 1 (Dec 2022) Adina Georgiana Dorobantu.pdf
Performance Review Form 1 (Dec 2022) Adina Georgiana Dorobantu.pdfAdinaGeorgiana7
 
Placement Presentation Adina Dorobantu 2023 (2).pptx
Placement Presentation Adina Dorobantu 2023 (2).pptxPlacement Presentation Adina Dorobantu 2023 (2).pptx
Placement Presentation Adina Dorobantu 2023 (2).pptxAdinaGeorgiana7
 
Second Meeting Instructions.docx
Second Meeting Instructions.docxSecond Meeting Instructions.docx
Second Meeting Instructions.docxAdinaGeorgiana7
 
First Meeting Instructions.docx
First Meeting Instructions.docxFirst Meeting Instructions.docx
First Meeting Instructions.docxAdinaGeorgiana7
 
B&C - Department Board - Minutes and Action Log - Nov.docx
B&C - Department Board - Minutes and Action Log - Nov.docxB&C - Department Board - Minutes and Action Log - Nov.docx
B&C - Department Board - Minutes and Action Log - Nov.docxAdinaGeorgiana7
 
Dorobantu Adina BMS2 - Molecular Biology FLR.pdf
Dorobantu Adina BMS2 - Molecular Biology FLR.pdfDorobantu Adina BMS2 - Molecular Biology FLR.pdf
Dorobantu Adina BMS2 - Molecular Biology FLR.pdfAdinaGeorgiana7
 
Careers action plan PSP2.doc
Careers action plan PSP2.docCareers action plan PSP2.doc
Careers action plan PSP2.docAdinaGeorgiana7
 
IBMS_portofolio_Dorobantu_Adina_Georgiana.pdf
IBMS_portofolio_Dorobantu_Adina_Georgiana.pdfIBMS_portofolio_Dorobantu_Adina_Georgiana.pdf
IBMS_portofolio_Dorobantu_Adina_Georgiana.pdfAdinaGeorgiana7
 
IntroBMS PortfolioGrid - Feedback.docx
IntroBMS PortfolioGrid - Feedback.docxIntroBMS PortfolioGrid - Feedback.docx
IntroBMS PortfolioGrid - Feedback.docxAdinaGeorgiana7
 
Lac Operon Feedback.docx
Lac Operon Feedback.docxLac Operon Feedback.docx
Lac Operon Feedback.docxAdinaGeorgiana7
 
Protein determination FLR - Feedback.docx
Protein determination FLR - Feedback.docxProtein determination FLR - Feedback.docx
Protein determination FLR - Feedback.docxAdinaGeorgiana7
 

More from AdinaGeorgiana7 (20)

Oral_Presentation_Submission Level 5.pptx
Oral_Presentation_Submission Level 5.pptxOral_Presentation_Submission Level 5.pptx
Oral_Presentation_Submission Level 5.pptx
 
Feedback on the Literature Review PSP3 CW
Feedback on the Literature Review PSP3  CWFeedback on the Literature Review PSP3  CW
Feedback on the Literature Review PSP3 CW
 
Adina Georgiana Dorobantu Literature review.pdf
Adina Georgiana Dorobantu Literature review.pdfAdina Georgiana Dorobantu Literature review.pdf
Adina Georgiana Dorobantu Literature review.pdf
 
3rd (Final) Performance Review Form - AGD Sept2023.pdf
3rd (Final) Performance Review Form - AGD Sept2023.pdf3rd (Final) Performance Review Form - AGD Sept2023.pdf
3rd (Final) Performance Review Form - AGD Sept2023.pdf
 
2nd Performance Review Form - ADjuly 2023 .pdf
2nd Performance Review Form - ADjuly 2023 .pdf2nd Performance Review Form - ADjuly 2023 .pdf
2nd Performance Review Form - ADjuly 2023 .pdf
 
Performance Review Form 1 (Dec 2022) Adina Georgiana Dorobantu.pdf
Performance Review Form 1 (Dec 2022) Adina Georgiana Dorobantu.pdfPerformance Review Form 1 (Dec 2022) Adina Georgiana Dorobantu.pdf
Performance Review Form 1 (Dec 2022) Adina Georgiana Dorobantu.pdf
 
Placement Presentation Adina Dorobantu 2023 (2).pptx
Placement Presentation Adina Dorobantu 2023 (2).pptxPlacement Presentation Adina Dorobantu 2023 (2).pptx
Placement Presentation Adina Dorobantu 2023 (2).pptx
 
Second Meeting Instructions.docx
Second Meeting Instructions.docxSecond Meeting Instructions.docx
Second Meeting Instructions.docx
 
First Meeting Instructions.docx
First Meeting Instructions.docxFirst Meeting Instructions.docx
First Meeting Instructions.docx
 
B&C - Department Board - Minutes and Action Log - Nov.docx
B&C - Department Board - Minutes and Action Log - Nov.docxB&C - Department Board - Minutes and Action Log - Nov.docx
B&C - Department Board - Minutes and Action Log - Nov.docx
 
Dorobantu Adina BMS2 - Molecular Biology FLR.pdf
Dorobantu Adina BMS2 - Molecular Biology FLR.pdfDorobantu Adina BMS2 - Molecular Biology FLR.pdf
Dorobantu Adina BMS2 - Molecular Biology FLR.pdf
 
PBoD CW.pdf
PBoD CW.pdfPBoD CW.pdf
PBoD CW.pdf
 
Careers action plan PSP2.doc
Careers action plan PSP2.docCareers action plan PSP2.doc
Careers action plan PSP2.doc
 
IBMS_portofolio_Dorobantu_Adina_Georgiana.pdf
IBMS_portofolio_Dorobantu_Adina_Georgiana.pdfIBMS_portofolio_Dorobantu_Adina_Georgiana.pdf
IBMS_portofolio_Dorobantu_Adina_Georgiana.pdf
 
IntroBMS PortfolioGrid - Feedback.docx
IntroBMS PortfolioGrid - Feedback.docxIntroBMS PortfolioGrid - Feedback.docx
IntroBMS PortfolioGrid - Feedback.docx
 
Oral Presentation.pptx
Oral Presentation.pptxOral Presentation.pptx
Oral Presentation.pptx
 
Lac Operon Feedback.docx
Lac Operon Feedback.docxLac Operon Feedback.docx
Lac Operon Feedback.docx
 
Protein determination FLR - Feedback.docx
Protein determination FLR - Feedback.docxProtein determination FLR - Feedback.docx
Protein determination FLR - Feedback.docx
 
Skills audit.docx
Skills audit.docxSkills audit.docx
Skills audit.docx
 
Refresher Lab Test.docx
Refresher Lab Test.docxRefresher Lab Test.docx
Refresher Lab Test.docx
 

Recently uploaded

BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.PraveenaKalaiselvan1
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...anilsa9823
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Patrick Diehl
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzohaibmir069
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxAleenaTreesaSaji
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxSwapnil Therkar
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfSwapnil Therkar
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfSELF-EXPLANATORY
 
Recombinant DNA technology( Transgenic plant and animal)
Recombinant DNA technology( Transgenic plant and animal)Recombinant DNA technology( Transgenic plant and animal)
Recombinant DNA technology( Transgenic plant and animal)DHURKADEVIBASKAR
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |aasikanpl
 
TOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsTOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsssuserddc89b
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxyaramohamed343013
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Sérgio Sacani
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...jana861314
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxUmerFayaz5
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Nistarini College, Purulia (W.B) India
 

Recently uploaded (20)

BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistan
 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptx
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
 
Recombinant DNA technology( Transgenic plant and animal)
Recombinant DNA technology( Transgenic plant and animal)Recombinant DNA technology( Transgenic plant and animal)
Recombinant DNA technology( Transgenic plant and animal)
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
 
TOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsTOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physics
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docx
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptx
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...
 

Dorobantu_A_Luminex-bead-based assay - Feedback.pdf

  • 1. Coursework Template for E-submission BMS Student name Adina Georgiana Dorobantu Student number 30019475 Module name Biomedical Investigations Title of coursework Luminex bead-based essay Instructions: 1) Complete your name and student number above. 2) Save your file as: YOUR surname_Initial_essay_2021-22.docx eg Cross_A_essay_2021-22.docx 3) Insert your work on page 2 so that the feedback form and marking criteria are on the last pages 4) Submit your work to the Blackboard submission tool on the Blackboard site, Submit your work as a Word file (not pdf). Insert learning contract details here if applicable.
  • 2. Technique based essay: Insert your work here Luminex bead-based assay Scientific Theory Since it was first discovered and introduced in 1995, the Luminex bead-based assay has revolutionized the approach of scientists in both research and clinical settings, due to the great advantages it brought to already existing techniques, the most common of which being the ELISA (Bourdon, 2016). Therefore, the objective of this technique guide is to create a comparative analysis between these two similar assays, while emphasizing the improvements brought on by Luminex through xMAP Luminex technology (see Table 1). The multiplex Luminex technology has been developed starting from and improving the concept of single-plex `sandwich` ELISA (can only detect one analyte at a time), where the antigen is caught between two different antibodies, one recognizing the antigen and one used for its detection of binding and therefore, its specific and sensitive quantification (“What is a Luminex Assay?,” 2017). Following the same concept, the principle behind xMAP Luminex technology is based on the use of color-coded 5.6 µm beads, which have been impregnated with different ratios of infrared and red dyes (fluorophores), allowing subsequent detection of unique bead regions specific for certain analytes, that can be identified on the resulting spectra (Principle of the Luminex Multiplex Bead Immunoassay Method, n.d.). Additionally, each bead is further coated with specific capture antibodies (Figure 1) (“What is a Luminex Assay?,” 2017). The multiplex feature of the Luminex assay comes with the advantage of being able to mix multiple specific beads depending on the required sample for analysis, in order to test for multiple analytes simultaneously, in the same amount of resources, such as sample volume, incubation time, reagent amounts, cost (“What is a Luminex Assay?,” 2017). The sample is added and left to incubate with the bead mixture, ensuring maximal binding and antibody saturation with analytes of interest, followed by a series of washing steps that ensure elimination of any unbound materials (Principle of the Luminex Multiplex Bead Immunoassay Method, n.d.). Then, a second biotinylated antibody linked to a streptavidin-phycoerythrin (PE) fluorescent reporter, also known as the detection antibody, is added to the mixture and incubated (Figure 1) (Principle of the Luminex Multiplex Bead Immunoassay Method, n.d.). The next step of the Luminex assay is the two-way flow cytometry detection system: firstly, a red laser is used for the excitation of the bead region, together with the bound analyte, respectively; secondly, a second green laser is used to determine the PE fluorescent reporter signal, which can also be correlated as having a directly proportional relationship to the amount of bound analyte (Figure 1) (“What is a Luminex Assay?,” 2017). In other words, the more analyte detected by the capture antibodies on certain bead-regions, the stronger the fluorescence signal, and therefore, the higher the value read by the xMAP Luminex analyser (“What is a Luminex Assay?,” 2017). Alternatively, measurement of this assay can also be done using the LED system (“What is a Luminex Assay?,” 2017). As an immunoassay, xMAP Luminex technology is currently being used in order to measure the `amount` of various analytes, such as cytokines, chemokines and other biomarkers, mostly present during an immunological response, which are essential in the better understanding of diseases and their manifestations (Günther, Becker, Göpfert, Joos, & Schneiderhan-Marra, 2020).
  • 3. For the purpose of the following and future analysis, it should be mentioned that variability is to be expected between different Luminex assay and ELISA kit producers. Figure 1. The mechanism behind the Luminex bead-based assay. This diagram outlines the successive steps of the Luminex assay. It depicts the Luminex bead (shown in red as a suggestion to the dyes used) with its capture antibody linked to it, which recognized the analyte of interest. Furthermore, the detection antibody with the linked PE reporter is also observed, as well as the overall bound complex, which is then measured by the use of red and green lasers (as seen on the right side of the diagram) Diagram retrieved from (Bourdon, 2016). Luminex bead-based assay ELISA Analyte capacity Multiplex Single-plex Ease of use  More accessible and easy to use  Easily adjustable (duPont, Wang, Wadhwa, Culhane, & Nelson, 2005)  Labour intenstive (duPont, Wang, Wadhwa, Culhane, & Nelson, 2005) Sample size  25 - 50 µL/ multiple samples  This directly influences and significantly lowers the cost of the assay (Mountjoy, 2020)  50 - 100 µL/ sample (recommended) (Mountjoy, 2020) Coating antibody (capture antibody) amount needed (/well)  7.5 ng (over 50x the amount needed for ELISA/well)  This is also reflected in a lower overall assay cost (Baker, Murphy, Lopez, & Garcia, 2012)  400 ng (Baker, Murphy, Lopez, & Garcia, 2012)
  • 4. Accuracy  Similar or equivalent for most analytes  However, this can be overcome by higher numbers of measured analytes in a shorter period of time (Shapiro, Wang, Mendu & Firpo, 2020)  Similar or equivalent  Slightly more accurate for a small number of analytes (Shapiro, Wang, Mendu & Firpo, 2020) Sensitivity  <4 pg/mL (Baker, Murphy, Lopez, & Garcia, 2012)  >31 pg/mL (Baker, Murphy, Lopez, & Garcia, 2012) Cross reactivity Low chance High chance Specificity and affinity  Optimal at the appropriate parameters for the analyzed sample (duPont, Wang, Wadhwa, Culhane, & Nelson, 2005)  Cross-reactivity can interfere (“Overview of ELISA | Thermo Fisher Scientific - UK,” 2022) Detection range  <4 pg/mL to >8000 pg/mL  Allows a broader range to be detected by the plate reader, between OD 3 or 4 (Baker, Murphy, Lopez, & Garcia, 2012)  16 pg/mL to 1000 pg/mL  Could restrict the plate reading ability due to the low upper limit (Baker, Murphy, Lopez, & Garcia, 2012) Time  ≤ 3h  Translates to higher throughout (Baker, Murphy, Lopez, & Garcia, 2012)  ≥ 24h  Translates to lower throughput (Baker, Murphy, Lopez, & Garcia, 2012) Cost Around 30% less compared to ELISA, due to smaller amounts of material needed for analysis of multiple analytes (£) (duPont, Wang, Wadhwa, Culhane, & Nelson, 2005) Higher cost, due to higher amount of materials needed for analysis of multiple analytes (£££) (duPont, Wang, Wadhwa, Culhane, & Nelson, 2005) Type pf plate and binding surface area  Carried out in 96-well or 384-well plates  Due to the beads being held in suspension, less capture antibody is required, as well as a lower sample amount (Baker, Murphy, Lopez, & Garcia, 2012)  Usually carried out in a 96- well or 384-well polystyrene plates  The flat-surface used requires increased capture antibody for coating the wells and a corresponding larger sample amount (Baker, Murphy, Lopez, & Garcia, 2012) Table 1. Comparative analysis between the Luminex bead-based assay and ELISA
  • 5. Applications A recent study “Evaluating SARS-CoV-2 spike and nucleoplasmid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay (Mariën et al., 2021) can be considered a very good example that proves the high and continuously developing applicability of this technique. The paper describes the context of choosing the Luminex bead assay, in the detriment of the already existing ELISA test that however, due to the high demand, is slowly becoming increasingly harder to sustain, financially, but also disadvantageous and inaccurate over a long period of time, because of suboptimal specificity and single-plex mechanism (Mariën et al., 2021). Moreover, the high accuracy, specificity and sensitivity of multiplex Luminex technology measuring the spike (S) and nucleoplasmid (NP) analytes was carried out on a diversity of recent and old infection cases, as well as sever, mild and asymptomatic cases (Mariën et al., 2021). The combination of two SARS-CoV-2 analytes as part of the multiplex Luminex assay generated considerably higher specificity, that could be used in future test developments, for example, to be distributed in underdeveloped countries, such as the sub-Saharan Africa, where occurrence of false-positive ELISA tests is elevated due to the influence of other infectious diseases (Mariën et al., 2021). The current relevance of this study demonstrates the reliability of the xMAP Luminex technology in easily adapting to development of novel diagnostic tests, even for a rapidly spreading infectious disease, which could only encourage an increasing interest in future diversification of this technique.
  • 6. Reference List Baker, H. N., Murphy, R., Lopez, E., & Garcia, C. (2012). Conversion of a Capture ELISA to a Luminex xMAP Assay using a Multiplex Antibody Screening Method. Journal of Visualized Experiments, (65). https://doi.org/10.3791/4084 Bourdon D. (2016, May 19). LuminexTM  bead-based immunoassays drive immunoassays towards higher-content biomarker discovery. Retrieved February 3, 2022, from Behind the Bench website: https://www.thermofisher.com/blog/behindthebench/luminex-bead-based-immunoassays-drive-immunoassays- towards-higher-content-biomarker-discovery/ duPont, N. C., Wang, K., Wadhwa, P. D., Culhane, J. F., & Nelson, E. L. (2005). Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture supernatants. Journal of Reproductive Immunology, 66(2), 175–191. https://doi.org/10.1016/j.jri.2005.03.005 Günther, A., Becker, M., Göpfert, J., Joos, T., & Schneiderhan-Marra, N. (2020). Comparison of Bead-Based Fluorescence Versus Planar Electrochemiluminescence Multiplex Immunoassays for Measuring Cytokines in Human Plasma. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.572634 Mariën, J., Ceulemans, A., Michiels, J., Heyndrickx, L., Kerkhof, K., Foque, N., … Ariën, K. K. (2021). Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay. Journal of Virological Methods, 288, 114025. https://doi.org/10.1016/j.jviromet.2020.114025 ‌ Mountjoy K.G. (2020) ELISA versus LUMINEX assay for measuring mouse metabolic hormones and cytokines: sharing the lessons I have learned. Retrieved February 3, 2022, from Journal of Immunoassay and Immunochemistry website: https://www.tandfonline.com/doi/full/10.1080/15321819.2020.1838924 Overview of ELISA | Thermo Fisher Scientific - UK. (2022). Retrieved February 3, 2022, from Thermofisher.com website: https://www.thermofisher.com/uk/en/home/life-science/protein-biology/protein-biology-learning-center/ protein-biology-resource-library/pierce-protein-methods/overview-elisa.html#:~:text=The%20enzyme%20linked %20immunosorbent%20assay,microplate%20wells%20using%20specific%20antibodies PRINCIPLE OF THE LUMINEX MULTIPLEX BEAD IMMUNOASSAY METHOD. (n.d.). Retrieved from https://cdn links.lww.com/permalink/sla/b/sla_2017_07_03_allen_annsurg-d-17-00426_sdc1.pdf (pp. 3, 7, 12-13)
  • 7. Shapiro, M S; Wang, X; Mendu, D R; Firpo (2020) Multiplex Assays of Luminex for Identification of COVID-19 Antibodies in Patient Serum: Performance Evaluation and Comparison to ELISA, A.American Journal of Clinical Pathology, suppl. 1; Chicago Vol. 154, (Oct 2020): S92. DOI:10.1093/ajcp/aqaa161.201, Retrieved February 3, 2022, from Proquest.com website: https://www.proquest.com/openview/d6c8b8d6d42fd46a252b18220b5f4213/1?pq- origsite=gscholar&cbl=586299 What is a Luminex Assay? (2017). Retrieved February 3, 2022, from www.rndsystems.com website: https://www.rndsystems.com/what-luminex-assay
  • 8. Faculty of Health and Wellbeing - Department of Biosciences ASSESSED WORK FEEDBACK FORM Student Name: Module Title: Biomedical Investigations Title of coursework Technique based structured essay Marker: Grade Strengths: Weaknesses and suggestions for improvement Student comments for Feed-forward (how will you use this feedback to improve your future work?): SIGNATURE DATE: *A provisional mark may be raised or lowered by the External Examiner or the Exam Board
  • 9. Indicator First (Exceptional) First (Excellent) Upper second (Very good) Lower Second (Good) Third (Sufficient) Fail (Insufficient) Low/Zero Fail Overall Knowledge and Understanding (weighting 20%) Shows advanced understanding of key subject area. Excellent level of originality with a wide range of relevant literature accessed. Excellent grasp of relevant literature and sound understanding of subject area. Evidence of originality. Very good understanding of the area. Appreciation of wider implications, and a serious attempt to engage with breadth of relevant literature Good understanding of subject area. Evidence of a reasonably sound engagement with relevant literature. May contain minor errors. Sufficient or inconsistent grasp of material. Evidence of some understanding of subject area. Limited research and major errors. Insufficient. Partial answer with major omissions. Poor understanding. Scarce amount of research. Little or no attempt to address the question. Brief or wholly irrelevant answer. Scientific theory with diagram (weighting 30%) Outstanding scientific theory. Clearly and concisely written. Flows well. Excellent diagram with clear explanatory legend Excellent theory, Clear and coherent. Excellent diagram with appropriate legend Very good theory. Clear and coherent. Clear diagram with appropriate legend Good explanation of theory. Diagram included. Figure legend included Sufficient explanation. Lacks coherence and clarity in many areas. Poor choice of diagram. Legend does not explain figure well. Insufficient theory. Explanation lacks focus. Incoherent, and lacks clarity throughout. Poor diagram, legend missing or irrelevant. Very poor with no structure or focus. No attempt at figure or figure legend Table of comparison to another technique (weighting 20%) Outstanding critical analysis. Excellent use of literature to illustrate comparisons Excellent standard of intelligent, critical thought and argument. Good use of literature to illustrate comparisons Very good evidence of independent thinking and critical analysis. Relevant material. Good evidence of critical analysis Limited use of literature to illustrate comparisons Sufficient/ weak critical analysis. An attempt to answer the question but may lack relevance and very little use of literature Unfocused. Insufficient engagement with literature No understanding of the issues and little attempt to address them Application of use (weighting 20%) Outstanding account of application discussed. Accurately communicated. Benefits fully explained Excellent understanding of the applications. Highly relevant applications incl. Clearly and effectively written. Benefits well explained Very good understanding of the applications. Relevant choices with some appropriate critique Benefits explained Good understanding of the applications discussed. Relevant choices made, benefits included Sufficient/ limited explanation of applications of use, unfocused and lacking depth. Insufficient attempt to explain applications, sources of information poor or inappropriate Little or no attempt to discuss applications of use Referencing (weighting 10%) Excellent and appropriate use of referencing throughout. No errors. Outstanding reference choice throughout Refs correct and thorough. Bibliography complete- properly laid out. Very minor errors. Excellent ref choice throughout References accurate. Bibliography complete and properly laid out. Minor errors. Very good ref. choice Generally correct but needs some attention. Some good reference choices Some incorrect referencing and incomplete or not properly laid out bibliography. Insufficient or no proper referencing. Bibliography inadequate. Poor choice of references No referencing Class CG% General Characteristics Level 5 9
  • 10. FIRST (Excellent} 96 Exceptional breadth and depth of knowledge and understanding of the area of study; evidence of extensive and appropriate selection and critical evaluation/synthesis/analysis and of reading/research beyond the prescribed range, in both breadth and depth, to advance work/direct arguments; exceptional demonstration of relevant skills; excellent communication; performance deemed to be beyond expectation. 89 81 Outstanding/excellent knowledge and understanding of the area of study as the student is typically able to go beyond what has been taught (particularly for a mid/high 1st ); evidence of extensive and appropriate selection and critical evaluation/synthesis/ analysis of reading/research beyond the prescribed range, to advance work/direct arguments; excellent demonstration of relevant skills; excellent communication; performance deemed beyond expectation of the level. 74 UPPER SECOND (Very good) 68 Very good knowledge and understanding of the area of study as the student is typically able to relate facts/concepts together with some ability to apply to known/taught contexts; evidence of appropriate selection and evaluation of reading/research, some beyond the prescribed range, may rely on set sources to advance work/direct arguments; demonstrates autonomy in approach to learning; very good demonstration of relevant skills; strong communication skills. 65 62 LOWER SECOND (Good) 58 Good knowledge and understanding of the area of study balanced towards the descriptive rather than analytical; evidence of appropriate selection and evaluation of reading/research but generally reliant on set sources to advance work/direct arguments; good demonstration of relevant skills, though may be limited in range; communication shows clarity but structure may not always be coherent. 55 52 THIRD (Sufficient) 48 Knowledge and understanding is sufficient to deal with terminology, basic facts and concepts but fails to make meaningful synthesis; some ability to select and evaluate reading/research however work may be more generally descriptive; strong reliance on available support set sources to advance work; arguments may be weak or poorly constructed; adequate demonstration of relevant skills over a limited range; communication/presentation is generally competent but with some weaknesses. 45 42 FAIL (Insufficient) 35 Insufficient knowledge and understanding of the area of study; some ability to select and evaluate reading/research however work is more generally descriptive; fails to address some aspects of the brief; a limited use of sources to advance work; arguments may be weak/poor or weakly/poorly constructed; demonstration of relevant skills over a reduced range; communication shows limited clarity, poor presentation, structure may not be coherent. 25 15 Highly insufficient knowledge or understanding of the area of study; understanding is typically at the word level with facts being reproduced in a disjointed or decontextualised manner; fails to address the outcomes addressed by the brief; typically ignores important sources in development of work and data/evidence inappropriately used; weak technical and practical competence hampers ability to demonstrate/communicate achievement of outcomes. 5 Zero 0 Work of no merit OR absent, work not submitted, penalty in some misconduct cases. 10